See other companies on Welcome to the Jungle
Imagen Technologies
Medical imaging software
- 101-200 employees
- Healthcare
- B2B
- Artificial Intelligence
- SaaS
- SoHo, New York, NY
Jump to section
Company mission
Imagen's mission is to save patient lives by making accurate medical image interpretation universally available and affordable.
Our take
Currently, over two-thirds of the world’s population doesn’t have access to basic radiology services. Artificial intelligence algorithms have tremendous potential to help health care providers diagnose and treat medical conditions where there are medical staff shortages. Imagen's technology aims to reduce radiology error rates and time taken to process x-rays. Long term, the company hopes to significantly reduce radiology costs, enabling better care globally.
Imagen Technologies takes its place in a competitive global artificial intelligence diagnostics market, which is expected to reach a value of $1.3 billion by 2026.
The company's OsteoDetect software is the first FDA-approved software able analyze wrist radiographs. The company raised $51 million in Series C funding in February 2021, to take their total funding to more than $135 million since 2015. They are using this funding to expand their product range and staff count.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Company Equity
- Fitness Subsidies
- Company sponsored family events
- Work from home opportunities
- Health insurance
Funding (last 2 of 5 rounds)
Nov 2024
$32m
LATE VC
Feb 2021
$51m
SERIES C
Total funding: $142.3m
This company has top investors
Leadership
Robert Lindsey
(Chief Technology Officer and Co-Founder)PhD from University of Colorado in Computer Science. Deep Learning Consultant and Research scientist at Boulder Analytics and Sensory Inc. respectively.
Aaron Daluiski
(Co-Founder)Hand surgeon specialising in paediatric and adult hand surgery with over 19 years of experience.
Alexander Dresner
(Co-CEO and Co-Founder)Investment Manager for Bridgewater Associates and Value Analyst at the Hospital of Special Surgery.
Robert Hotchkiss
(Co-Founder)Medical Director of Innovation at the Hospital of Special Surgery.